Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Completed · Phase 2

Conditions studied: Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.

Key facts

Study ID

NCT00002524

Run by

M.D. Anderson Cancer Center

People needed

46

Starts

1993-06-01

Expected to finish

2005-10-01

Last updated by the study team

2012-07-30

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• MD Anderson Cancer Center Orlando — Orlando, Florida, United States
• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.